Executive Conference Sponsors

	Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential — to see more clearly, move more freely, express themselves more fully. Our focus fosters deep engagement with medical specialists and we make it our business to listen closely to their needs so that together we can advance patient care. We combine this strategic focus with a diversified approach that enables us to follow our research and development into new specialty areas where unmet needs are significant.

	Boehringer Ingelheim Pharmaceuticals, Inc., the US subsidiary of Boehringer Ingelheim, headquartered in Germany, operates globally in 50 countries with more than 41,500 employees. The company is committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. For more information please visit http://us.boehringer-ingelheim.com.

	KCI is committed to helping patients harness the body’s power to heal and regenerate. For more than thirty years, KCI has led the way in the development of new technologies, and therapies designed to make wound healing more manageable for caregivers and more comfortable for patients around the world. KCI believes in offering the medical community and patients the most advanced treatments available. That’s why it employs more than 7,000 people dedicated to developing game-changing innovations and providing the best service and clinical support in more than 20 nations. All over the world, KCI is elevating patient outcomes, lowering costs and delivering the advanced treatments necessary to heal and improve lives.

	The AFib Support Team presentation, sponsored by sanofi-aventis U.S. LLC, is intended to provide valuable insights on the need for comprehensive management and education about atrial fibrillation (AFib). A primary goal of the AFib Support Team is to provide health care providers with the information and tools needed to improve their patients’ understanding of AFib as a serious and chronic disease. In addition, strategies to improve outcomes through a productive patient dialogue are highlighted. This presentation is designed specifically for registered nurses, nurse practitioners, and physician assistants who manage the treatment of patients with AFib.

	At Optum, our work gives us a unique perspective. Because we serve people throughout the entire health system — from those who promote wellness and prevention, to those who provide care, to those who research, manage and deliver medications — we can see the bigger picture. We are comprised of three market-leading business segments — OptumHealth, OptumInsight and OptumRx. And together, we deliver integrated, intelligent solutions that work to modernize the health system, improve overall population health and build and enable Sustainable Health Communities.